相关实验视频

Updated: Jun 2, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

在体外膜氧化期间的抗凝血作用

Troy Seelhammer¹, Jacob Ninan², Scott Nei³

¹Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA.

The Cochrane database of systematic reviews

|January 13, 2025

概括

本"柯克伦评审"协议检查了心脏或呼吸系统衰竭的患者体外膜氧化 (ECMO) 的抗凝剂. 它旨在评估这种干预措施在所有年龄段的有效性和安全性.

科学领域:

关键护理医学关键护理医学
心血管医学心血管医学
呼吸系统药物呼吸系统药物

背景情况:

身体外膜氧化 (ECMO) 提供了重要的心肺呼吸支持.
抗凝药对于预防ECMO期间的电路血栓形成至关重要.
最佳的抗凝策略需要进一步研究.

研究的目的:

评估抗凝固剂在维持ECMO方面的有效性.
在ECMO期间评估抗凝固疗法的安全性.
综合所有需要ECMO的年龄组的证据.

主要方法:

这是柯克伦审查的协议.
将采用系统审查方法.
专注于评估ECMO抗凝剂的干预研究.

主要成果:

结果正在等待系统审查的完成.
将分析抗凝血剂的疗效数据.
将报告安全数据,包括出血和血栓形成事件.

结论:

在综合证据后,将得出结论.
结果将为ECMO抗凝药的临床实践指南提供信息.
将确定未来的研究方向.

更多相关视频

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

相关概念视频

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...